28th International Workshop on Retroviral Pathogenesis

第28届逆转录病毒发病机制国际研讨会

基本信息

  • 批准号:
    9189824
  • 负责人:
  • 金额:
    $ 0.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-08-01 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The International Workshop on Retroviral Pathogenesis, now in its 28th year, has long served as a forum for the exchange of new research findings and concepts on all aspects of retroviral pathogenesis from molecular mechanisms to the immunological parameters of host-virus interaction. The conference will continue a tradition of intimate, engaged scientific interaction on all aspects of retroviral pathogenesis with strong emphasis on animal retroviruses as models for human disease. Retroviral pathogens of humans and animals in all retroviral genera are the subject of scientific presentation and vibrant discussion. Topics at the workshop will include retrovirus entry and integration, replication and restriction, assembly, immune responses, oncogenesis, pathogenesis, new and emerging pathogens, endogenous retroviruses, and animal models of disease. Approximately 75 participants are anticipated, including principal investigators, postdoctoral trainees and graduate students. Planned for December 5 – 9, 2016 in New Orleans, Louisiana, the small size and format of the conference supports concentrated interaction and deep scientific engagement. The conference fosters the professional development of junior investigators by affording them the opportunity to present their current work to a panel of engaged colleagues and to serve as session moderators. The overarching goal of the conference is to provide a forum that fosters continued scientific engagement leading to innovative conceptual advances and research in the area of retroviral pathogenesis, broadly defined. The conference will address this goal through four specific aims: (1) Bring together national and international scientific leaders in the field, together with junior investigators, postdoctoral and student trainees; (2) Provide opportunities for scientific presentations and discussions as a group, interspersed with more intimate opportunity for discussion and interaction; (3) Provide platform opportunities for junior investigators, women and underrepresented minority scholars through scientific presentation and/or designation as session moderators; and (4) Provide registration scholarships to outstanding undergraduate students and a faculty advisor selected among participants in the NIH-funded “Building Integrated Pathways to Independence for Diverse Biomedical Researchers (BUILD)” Program at Xavier University, a leading HBCU located in the conference city.
项目总结/摘要 国际逆转录病毒发病机制研讨会已举办28年,长期以来一直是 就逆转录病毒的各个方面交流新的研究结果和概念的论坛 从分子机制到宿主病毒免疫参数的发病机制 互动会议将继续保持亲密,参与科学互动的传统, 逆转录病毒发病机制的所有方面,特别强调动物逆转录病毒作为模型, 人类疾病。人类和动物的所有逆转录病毒属的逆转录病毒病原体是 科学陈述和热烈讨论的主题。研讨会的主题将包括 逆转录病毒进入和整合,复制和限制,装配,免疫应答, 肿瘤发生、发病机制、新的和新兴的病原体、内源性逆转录病毒,以及 疾病的动物模型。预计约有75名与会者,包括主要的 研究人员、博士后实习生和研究生。计划于2016年12月5 - 9日 在路易斯安那州的新奥尔良,会议的规模和形式都很小, 互动和深入的科学参与。会议培养专业人士 初级调查员的发展,让他们有机会介绍他们目前的 与一个由参与的同事组成的小组合作,并担任会议主持人。总体 会议的目标是提供一个论坛,促进持续的科学参与, 在逆转录病毒发病机制领域的创新概念进展和研究, 定义了会议将通过四个具体目标来实现这一目标:(1)汇集 该领域的国家和国际科学领导人,以及初级研究人员, (2)提供科学报告的机会, 作为一个小组进行讨论,穿插着更亲密的讨论机会, (3)为初级调查员、妇女和 通过科学陈述和/或指定为 会议主持人;及(4)提供注册奖学金,以优秀的本科生 学生和一名教员顾问从NIH资助的“建设”项目的参与者中选出, 不同生物医学研究人员独立的综合途径(BUILD) 泽维尔大学,一个领先的HBCU位于会议城市。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura S Levy其他文献

Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-β1 and IL-6
  • DOI:
    10.1186/1471-2407-7-35
  • 发表时间:
    2007-02-26
  • 期刊:
  • 影响因子:
    3.400
  • 作者:
    Kristin R Ruff;Adriane Puetter;Laura S Levy
  • 通讯作者:
    Laura S Levy
A Thank You from Tulane University
杜兰大学的感谢信
  • DOI:
    10.1126/science.316.5823.367c
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    56.9
  • 作者:
    Laura S Levy
  • 通讯作者:
    Laura S Levy

Laura S Levy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura S Levy', 18)}}的其他基金

Selective Forces Operative in FeLV Infection
FeLV 感染中起作用的选择性力量
  • 批准号:
    7911087
  • 财政年份:
    2009
  • 资助金额:
    $ 0.5万
  • 项目类别:
IMMUNOBIOLOGY OF SAIDS-ASSOCIATED LYMPHOMAS
SAIDS 相关淋巴瘤的免疫生物学
  • 批准号:
    7562246
  • 财政年份:
    2007
  • 资助金额:
    $ 0.5万
  • 项目类别:
IMMUNOBIOLOGY OF SAIDS-ASSOCIATED LYMPHOMAS
SAIDS 相关淋巴瘤的免疫生物学
  • 批准号:
    7348971
  • 财政年份:
    2006
  • 资助金额:
    $ 0.5万
  • 项目类别:
IMMUNOBIOLOGY OF SIV-ASSOCIATED LYMPHOMAS
SIV 相关淋巴瘤的免疫生物学
  • 批准号:
    7165016
  • 财政年份:
    2005
  • 资助金额:
    $ 0.5万
  • 项目类别:
IMMUNOBIOLOGY OF SIV-ASSOCIATED LYMPHOMAS
SIV 相关淋巴瘤的免疫生物学
  • 批准号:
    6970714
  • 财政年份:
    2004
  • 资助金额:
    $ 0.5万
  • 项目类别:
IMMUNOBIOLOGY OF SIV-ASSOCIATED LYMPHOMAS
SIV 相关淋巴瘤的免疫生物学
  • 批准号:
    6939802
  • 财政年份:
    2003
  • 资助金额:
    $ 0.5万
  • 项目类别:
SELECTIVE FORCES OPERATIVE IN FELV INFECTION
选择性力量在FELV感染中发挥作用
  • 批准号:
    6497940
  • 财政年份:
    2000
  • 资助金额:
    $ 0.5万
  • 项目类别:
SELECTIVE FORCES OPERATIVE IN FELV INFECTION
选择性力量在FELV感染中发挥作用
  • 批准号:
    6628424
  • 财政年份:
    2000
  • 资助金额:
    $ 0.5万
  • 项目类别:
SELECTIVE FORCES OPERATIVE IN FELV INFECTION
选择性力量在FELV感染中发挥作用
  • 批准号:
    6702206
  • 财政年份:
    2000
  • 资助金额:
    $ 0.5万
  • 项目类别:
SELECTIVE FORCES OPERATIVE IN FELV INFECTION
选择性力量在FELV感染中发挥作用
  • 批准号:
    6027861
  • 财政年份:
    2000
  • 资助金额:
    $ 0.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了